| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PATH.1711590203 |
| P698 | PubMed publication ID | 2681628 |
| P2093 | author name string | Smith EB | |
| Thompson WD | |||
| P2860 | cites work | Clonal markers in the study of the origin and growth of human atherosclerotic lesions | Q44342680 |
| P433 | issue | 2 | |
| P304 | page(s) | 97-106 | |
| P577 | publication date | 1989-10-01 | |
| P1433 | published in | Journal of Pathology | Q400296 |
| P1476 | title | Atherosclerosis and the coagulation system | |
| P478 | volume | 159 |
| Q41847991 | A study of plasma fibrinogen level in type-2 diabetes mellitus and its relation to glycemic control |
| Q40430415 | Arterial thrombosis for the clinician. Pathobiology and emerging concepts. |
| Q90264340 | Cardiotonic Pills Plus Recombinant Human Prourokinase Ameliorates Atherosclerotic Lesions in LDLR-/- Mice |
| Q36889156 | Diabetes mellitus as a prothrombotic condition |
| Q34990662 | Effects of lipids on thrombotic mechanisms in atherosclerosis |
| Q34265807 | Exercise and heart disease: cardiac findings in fatal cycle accidents |
| Q72049303 | Fibrinogen and Silent Atherosclerosis in Subjects With Cardiovascular Risk Factors |
| Q51022348 | Fibrinogen levels in women having coronary angiography. |
| Q35348836 | Fibrinogen/fibrin in atherogenesis |
| Q40744822 | Fibrinogen: an important risk factor for atherothrombotic diseases |
| Q40725303 | Fibrinogen: its emerging role as a cardiovascular risk factor |
| Q42044417 | Fibrinolysis and angiogenesis in wound healing |
| Q40582633 | Fibrinolysis and thrombosis |
| Q52274072 | Fish oil may be an antidote for the cardiovascular risk of smoking. |
| Q45884243 | Haemostasis balance disorders in patients with essential hypertension |
| Q41675668 | Hemostatic concomitants of syndrome X |
| Q37220515 | Homocysteine and fibrinogen changes with L-thyroxine in subclinical hypothyroid patients |
| Q31920320 | In situ detection of tissue factor within the coronary intima in rat cardiac allograft vasculopathy |
| Q37374639 | Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis |
| Q44431760 | Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm. |
| Q48754609 | Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS). |
| Q40948177 | Metabolic abnormalities in cardiac ischemia. |
| Q51580851 | No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids. |
| Q43812330 | Patients on peritoneal dialysis but not on hemodialysis have elevated concentration and activity of thrombin-activatable fibrinolysis inhibitor |
| Q50949758 | Plasma fibrinogen concentration in a Chinese population. |
| Q33832519 | Plasma plasminogen activator inhibitor 1, insulin resistance and android obesity |
| Q48751421 | Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men. |
| Q51565504 | The effects of structurally defined triglycerides of differing fatty acid composition on postprandial haemostasis in young, healthy men. |
| Q46466743 | The influence of type 2 diabetes on fibrin structure and function |
| Q57791595 | Thrombosis and hemostasis in renal disease |
| Q34119720 | Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions |
Search more.